Literature DB >> 3960276

Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats.

T S King, R W Steger, W W Morgan.   

Abstract

Accumulations of 5-hydroxytryptophan (5HTP) and L-dihydroxyphenylalanine (L-DOPA) following decarboxylase inhibition as indices for 5-hydroxytryptamine (5HT) and catecholamine (dopamine and/or norepinephrine) synthesis, respectively, were both increased in the preoptic area-anterior hypothalamus (POA-AH) of ovariectomized rats treated with a combination of 17 beta-estradiol benzoate (E2) and progesterone (P). Similarly, an increased accumulation of L-DOPA was seen in the mediobasal hypothalamus (MBH) and median eminence (ME) of these animals although no change was observed in 5HTP accumulation in the MBH or ME of these rats. Hypophysectomy negated these steroid-induced effects on L-DOPA accumulation. However, hypophysectomy had no apparent effect on steroid-stimulated 5HTP accumulation in the POA-AH of these rats. Under the experimental conditions of our study, the results suggest that the stimulatory effect of ovarian steroids on hypothalamic catecholamine synthesis is dependent on an intact pituitary gland, that the stimulatory effect of ovarian steroids on 5HT synthesis in the POA-AH is not dependent on an intact pituitary gland, and (3) that ovarian steroids do not seem to influence 5HT synthesis in the ME or MBH. The significance of these results may lie in the function of these hypothalamic monoaminergic neurotransmitter systems to regulate gonadotrophin release and subsequent steroid feedback modulation of such central regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3960276     DOI: 10.1159/000124461

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Lynda T Wells; Christopher L Wallace; Michael A Dawes; Lei Liu; Xin-Qun Wang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-09-15       Impact factor: 5.067

2.  Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.

Authors:  Bankole A Johnson; Lynda T Wells; John D Roache; Christopher L Wallace; Nassima Ait-Daoud; Michael A Dawes; Lei Liu; Xin-Qun Wang; Martin A Javors
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-12-19       Impact factor: 5.067

Review 3.  Ovarian steroids and serotonin neural function.

Authors:  C L Bethea; M Pecins-Thompson; W E Schutzer; C Gundlah; Z N Lu
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

4.  Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Erik W Gunderson; Heather M Haughey; Xin-Qun Wang; Lei Liu
Journal:  Addict Biol       Date:  2012-10-08       Impact factor: 4.280

5.  Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques.

Authors:  M Pecins-Thompson; N A Brown; S G Kohama; C L Bethea
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

6.  Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Christopher Wallace; Lynda T Wells; Yanmei Wang
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

7.  The Role of Estrogen Receptor β in the Dorsal Raphe Nucleus on the Expression of Female Sexual Behavior in C57BL/6J Mice.

Authors:  Kazuhiro Sano; Chihiro Morimoto; Mariko Nataka; Sergei Musatov; Mumeko C Tsuda; Naoko Yamaguchi; Toshiro Sakamoto; Sonoko Ogawa
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.